The efficacy of maintenance therapy after remission induction with tacrolimus in ulcerative colitis with and without previous tumor necrosis factor‐α inhibitor

BACKGROUND AND AIM: Tacrolimus (TAC) is an important therapeutic option for remission induction in patients with refractory ulcerative colitis (UC). However, there is little evidence available on long‐term outcomes and maintenance treatments after TAC therapy, especially in cases with previous tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Taketo, Mizoshita, Tsutomu, Tanida, Satoshi, Sugimura, Naomi, Katano, Takahito, Nishie, Hirotada, Kataoka, Hiromi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586576/
https://www.ncbi.nlm.nih.gov/pubmed/31276039
http://dx.doi.org/10.1002/jgh3.12140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586576/
https://www.ncbi.nlm.nih.gov/pubmed/31276039
http://dx.doi.org/10.1002/jgh3.12140

Ejemplares similares